Vactosertib
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Vactosertib, covering 2022-06-15 to 2025-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer [Phase 1]